Global Health

1,196.60
-13.60
(-1.12%)
Market Cap
32,139.17 Cr
EPS
12.58
PE Ratio
62.62
Dividend Yield
0.04 %
52 Week High
1,378.70
52 Week Low
935.50
PB Ratio
9.59
Debt to Equity
0.55
Sector
Hospitals
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from11 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+63.64 %
+63.64 %
Hold
Hold+18.18 %
+18.18 %
Sell
Sell+18.18 %
+18.18 %
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,130.40
#1 1,09,890.94
98.86
5,584.10
18.77
#1 1,058
26.84
51.53
6,901.00
99,225.79
76.28
#1 19,165.50
14.74
917
49.14
50.68
716.90
54,122.95
63.40
6,931.20
8.99
645
-7.43
58.47
1,774.60
36,265.87
44.21
5,093.40
10.96
790
3.41
45.69
1,196.60
#5 32,139.17
#5 62.62
#6 2,759.20
#1 25.09
#6 326
#10 -20.35
49.96
538.95
26,921.26
73.01
3,723.70
22.85
205
#1 3,986.36
52.05
649.50
25,989.02
69.19
2,511.20
12.94
336
48.39
51.21
5,836.55
14,790.43
#1 31.63
599.90
11.69
58
4.79
57.85
1,399.30
14,210.13
58.71
1,334.00
10.76
218
10.57
57.52
1,441.30
9,450.03
49.01
1,095.50
21.32
177
-0.88
49.82

Automatic Screeners on ScanX

Forecast
Actual
Growth Rate
Revenue Growth
25.09 %
Net Income Growth
66.21 %
Cash Flow Change
107.07 %
ROE
10.63 %
ROCE
12.64 %
EBITDA Margin (Avg.)
10.54 %

Quarterly Financial Results

Quarterly Financials
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
492
588
593
533
627
695
706
732
795
865
855
836
883
975
960
954
Expenses
386
442
448
441
485
523
534
540
595
631
621
629
675
728
706
757
EBITDA
106
146
146
92
142
172
172
192
199
234
234
207
208
247
254
198
Operating Profit %
21 %
24 %
23 %
15 %
21 %
23 %
23 %
24 %
24 %
25 %
26 %
22 %
22 %
24 %
25 %
19 %
Depreciation
31
31
33
35
36
37
39
38
40
43
44
46
47
49
49
49
Interest
16
17
18
28
19
18
21
21
18
20
18
18
18
16
16
15
Profit Before Tax
58
98
95
29
87
117
112
133
141
171
172
143
144
181
189
133
Tax
16
31
25
12
28
31
32
32
39
45
49
16
37
50
46
32
Net Profit
42
67
70
18
59
86
81
101
102
125
124
127
106
131
143
101
EPS in ₹
5.13
13.22
2.76
0.69
2.32
3.38
3.08
3.77
3.80
4.66
4.61
4.74
3.96
4.87
5.32
3.77

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
Total Assets
1,984
2,430
2,666
2,694
3,146
4,116
Fixed Assets
1,094
1,194
1,703
1,616
1,776
2,050
Current Assets
472
489
479
502
812
1,580
Capital Work in Progress
317
666
382
464
439
327
Investments
0
0
0
0
0
0
Other Assets
573
570
582
615
930
1,739
Total Liabilities
1,984
2,430
2,666
2,694
3,146
4,116
Current Liabilities
334
296
358
405
420
573
Non Current Liabilities
432
839
959
907
1,110
1,115
Total Equity
1,217
1,296
1,350
1,382
1,616
2,428
Reserve & Surplus
1,136
1,214
1,268
1,300
1,565
2,375
Share Capital
81
49
49
50
51
54

Cash Flow

Cash Flow
2015
2016
2018
2019
2020
2021
2022
2023
Net Cash Flow
-0
-20
3
14
87
-78
50
648
Investing Activities
-126
-241
-69
-249
-87
-239
-421
-342
Operating Activities
213
228
63
166
175
242
311
645
Financing Activities
-88
-7
9
97
-1
-81
160
346

Share Holding

% Holding
Sept 2021
Oct 2022
Nov 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
35.04 %
35.03 %
33.08 %
33.08 %
33.08 %
33.07 %
33.06 %
33.05 %
33.04 %
33.04 %
33.04 %
33.03 %
33.03 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
10.69 %
0.00 %
12.09 %
12.94 %
12.20 %
12.47 %
11.76 %
DIIs
0.00 %
0.00 %
7.78 %
12.55 %
12.35 %
10.80 %
10.93 %
9.68 %
10.25 %
10.57 %
11.11 %
10.51 %
11.93 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
25.44 %
6.16 %
5.77 %
6.79 %
6.85 %
6.79 %
7.14 %
6.28 %
6.54 %
6.74 %
6.53 %
Others
64.96 %
64.97 %
33.69 %
48.21 %
48.80 %
49.34 %
38.48 %
50.48 %
37.47 %
37.16 %
37.10 %
37.24 %
36.75 %
No of Share Holders
47
48
2,86,944
1,21,407
1,07,120
1,09,798
1,16,627
1,24,775
1,66,253
1,55,307
1,49,722
1,48,633
1,54,688

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
15 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
15 May 2025 1,203.60 1,241.80
04 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
04 Feb 2025 1,001.20 1,042.50
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 1,073.35 1,032.55
19 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
19 Sept 2024 1,191.50 1,113.90
03 Aug 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
03 Aug 2024 1,306.70 1,209.25

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation2 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation2 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation2 days ago
Compliances-Reg.24(A)-Annual Secretarial Compliance5 days ago
Declaration Under Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 20156 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation7 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation7 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation7 days ago
Announcement under Regulation 30 (LODR)-Earnings Call Transcript7 days ago
Announcement under Regulation 30 (LODR)-Investor PresentationMay 16, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 16, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 16, 2025
Key Performance Indicators (Kpis) For FY 2024-25May 15, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 15, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 15, 2025
Amendment In The Code Of Conduct Pursuant To Regulation 8 & 9 Of SEBI (Prohibition Of Insider Trading) Regulation 2015May 15, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 15, 2025
Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 15, 2025
Results For The Quarter And Financial Year Ended March 31 2025May 15, 2025
Board Meeting Outcome for Intimation Under Regulation 30 Of SEBI Listing RegulationMay 15, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 15, 2025
Announcement under Regulation 30 (LODR)-Meeting UpdatesMay 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 09, 2025
Board Meeting Intimation for Board Meeting Intimation Regarding Approval Of Financial Results For The Quarter And Financial Year Ending March 31 2025 And Recommendation Of Final Dividend.May 05, 2025
Board Meeting Outcome for Intimation Under Regulation 30 Of SEBI LODR RegulationApr 28, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 28, 2025
Announcement under Regulation 30 (LODR)-Meeting UpdatesApr 28, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementApr 14, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementApr 08, 2025
Announcement under Regulation 30 (LODR)-Meeting UpdatesApr 08, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)Apr 07, 2025
Closure of Trading WindowMar 27, 2025
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationMar 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 22, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 22, 2025
Announcement under Regulation 30 (LODR)-Credit RatingMar 18, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotMar 17, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 04, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 01, 2025
Announcement under Regulation 30 (LODR)-Scheme of ArrangementMar 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 21, 2025
Announcement under Regulation 30 (LODR)-Scheme of ArrangementFeb 21, 2025
Announcement under Regulation 30 (LODR)-Scheme of ArrangementFeb 20, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 15, 2025

Technical Indicators

RSI(14)
Neutral
49.96
ATR(14)
Less Volatile
33.38
STOCH(9,6)
Neutral
40.55
STOCH RSI(14)
Neutral
62.10
MACD(12,26)
Bullish
0.78
ADX(14)
Weak Trend
16.56
UO(9)
Bearish
59.02
ROC(12)
Downtrend And Accelerating
-1.38
WillR(14)
Neutral
-41.90

Mutual Fund Holdings

Funding HouseNo of SharesCurrent Holding %1M Change %3M Change %Month
HDFC Pharma And Healthcare Fund Direct - Growth
0
0.00%
-1.85%
-1.98%
Apr 2025
LIC MF Healthcare Fund Direct - Growth
16694
2.37%
-1.13%
-1.44%
Apr 2025
JM ELSS Tax Saver Fund Direct Plan-Growth
0
0.00%
-1.11%
-1.17%
Apr 2025
LIC MF Small Cap Fund Direct - Growth
0
0.00%
-0.98%
-1.07%
Apr 2025
Invesco India Multicap Fund Direct-Growth
231037
0.73%
0.73%
0.73%
Apr 2025
LIC MF Midcap Fund Direct - Growth
22720
0.89%
-0.67%
-0.74%
Apr 2025
Motilal Oswal Innovation Opportunities Fund Direct-Growth
65922
4.98%
-0.57%
3.44%
Apr 2025
JM Aggressive Hybrid Fund Direct-Growth
56252
0.84%
-0.56%
-0.57%
Apr 2025
Invesco India Smallcap Fund Direct - Growth
1501706
2.90%
0.41%
0.44%
Apr 2025
Navi Nifty Midcap 150 Index Fund Direct - Growth
0
0.00%
-0.32%
-0.33%
Apr 2025
Invesco India Focused Fund Direct - Growth
1368138
4.43%
-0.21%
-0.22%
Apr 2025
Invesco India Aggressive Hybrid Fund Direct - Growth
59135
1.08%
0.16%
0.27%
Apr 2025
Invesco India Mid Cap Fund Direct-Growth
1383806
2.74%
-0.13%
-0.29%
Apr 2025
Invesco India Large & Mid Cap Fund Direct-Growth
1358479
2.40%
-0.13%
-0.23%
Apr 2025
JM Small Cap Fund Direct - Growth
76560
1.45%
0.11%
0.04%
Apr 2025
PGIM India Multi Cap Fund Direct-Growth
59095
1.94%
-0.11%
-0.18%
Apr 2025
HSBC Consumption Fund Direct - Growth
384300
3.09%
-0.11%
-0.17%
Apr 2025
Invesco India Flexi Cap Fund Direct - Growth
335486
1.46%
-0.10%
-0.19%
Apr 2025
PGIM India Healthcare Fund Direct-Growth
26471
2.95%
-0.09%
-0.20%
Apr 2025
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth
36047
1.35%
-0.08%
-0.18%
Apr 2025
PGIM India Hybrid Equity Fund Direct Plan-Growth
38540
2.19%
-0.08%
-0.05%
Apr 2025
Navi Nifty 500 Multicap 50:25:25 Index Fund Direct-Growth
0
0.00%
-0.08%
-0.08%
Apr 2025
LIC MF Aggressive Hybrid Fund Direct-Growth
48198
1.14%
-0.07%
-0.09%
Apr 2025
PGIM India Large and Mid Cap Fund Direct - Growth
56526
1.04%
-0.06%
-0.10%
Apr 2025
WhiteOak Capital Quality Equity Fund Direct-Growth
48460
1.40%
0.06%
-0.02%
Apr 2025

About Global Health

Global Health Limited is a private multi-specialty tertiary care provider operating in North and East India. Founded by Dr. Naresh Trehan, the company operates under the Medanta brand with a network of 5 operational hospitals and one under construction. As of June 30, 2022, they offered healthcare services in over 30 medical specialties, employed over 1,300 doctors, and had 2,467 installed beds across 4.7 million sq. ft. of area. The company operates hospitals in Gurugram, Indore, Ranchi, Lucknow, and Patna, with specialties including cardiology, neurosciences, oncology, and orthopedics. Global Health Limited went public in November 2022, raising Rs. 2205.57 crores through an IPO. The company has been expanding its facilities, adding beds, doctors, and new medical equipment across its hospitals.
Listing Date
16 Nov, 2022(2 Years, 43 days)
Chairperson NameNaresh Kumar Trehan